TRACON Pharmaceuticals Announces Poster Presentations for Envafolimab and TRC102 at the 2023 ASCO Annual Meeting
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage…
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage…
New data show continued durability of response over 14 months with humoral immune responses increasing…
New data show continued durability of response over 14 months with humoral immune responses increasing…
BRISBANE, Calif., May 30, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage…
BRISBANE, Calif., May 30, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage…
CHICAGO and FORT WORTH, Texas, May 30, 2023 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (Actuate),…
CHICAGO and FORT WORTH, Texas, May 30, 2023 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (Actuate),…
WATERTOWN, Mass., May 30, 2023 (GLOBE NEWSWIRE) — Larkspur Biosciences, a biotechnology company building the…
WATERTOWN, Mass., May 30, 2023 (GLOBE NEWSWIRE) — Larkspur Biosciences, a biotechnology company building the…
Selected for Oral Presentation Study done in the CMT1A mouse model Supported by the CMT…
Selected for Oral Presentation Study done in the CMT1A mouse model Supported by the CMT…
Reports significant uptick in enrollment activities Tigris trial enrollment at 61 patients TORONTO, May 30,…
Reports significant uptick in enrollment activities Tigris trial enrollment at 61 patients TORONTO, May 30,…
Lead asset CT-01 on track for clinical trial application authorization in Q3 2023 Collaboration with…
Lead asset CT-01 on track for clinical trial application authorization in Q3 2023 Collaboration with…
OLON ENTERS IN ADC MARKET Olon facility MILAN, Italy, May 30, 2023 (GLOBE NEWSWIRE) —…
OLON ENTERS IN ADC MARKET Olon facility MILAN, Italy, May 30, 2023 (GLOBE NEWSWIRE) —…
Expect to report initial clinical data for FLT201 in Gaucher disease in third quarter of…
Expect to report initial clinical data for FLT201 in Gaucher disease in third quarter of…
– Late-breaking abstracts scheduled for publication on the EHA website at 16:00 CET on Thursday,…